TrialThe Journal of infectious diseases2016

No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.

Paul T Edlefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.